SCHEMBL4356298

SCHEMBL4356298

COc1ccc(F)cc1C(=O)c1cnc(NCCCN2CCCC2=O)nc1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 4/20 0.54
CDK4 P11802 3/20 0.54
CCND1 P24385 3/20 0.54
CDK2 P24941 3/20 0.54
TYRO3 Q06418 9/20 0.51
MERTK Q12866 3/20 0.51
MET P08581 2/20 0.51
AXL P30530 2/20 0.51
IKBKB O14920 1/20 0.51
ABL1 P00519 1/20 0.51
INSR P06213 1/20 0.51
SRC P12931 1/20 0.51
MAPK1 P28482 1/20 0.51
GSK3B P49841 1/20 0.51
PIM2 Q9P1W9 1/20 0.51
CASK O14936 1/20 0.50
SELP P16109 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
PGK1 P00558 1/20 0.46
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4358772 0.83 CDK1 (0.56) CDK1CDK4CCND1CDK2ABL1
SCHEMBL4352509 0.82 CDK1 (0.56) CDK1CDK4CCND1CDK2ABL1
SCHEMBL4352534 0.79 CDK1 (0.59) CDK1CDK4CCND1CDK2ABL1
SCHEMBL3524063 0.79 CDK1 (0.59) CDK1CDK4CCND1CDK2ABL1
SCHEMBL4359245 0.77 CDK1 (0.55) CDK1CDK4CCND1CDK2MAPK1
SCHEMBL4354378 0.77 CDK1 (0.51) CDK1CDK4CCND1CDK2AXL
SCHEMBL13632163 0.76 CDK1 (0.63) CDK1CDK4CCND1CDK2ABL1
SCHEMBL4354535 0.75 CDK1 (0.53) CDK1CDK4CCND1CDK2
SCHEMBL4352343 0.73 CDK4 (0.81) CDK1CDK4CCND1CDK2MAPK1
SCHEMBL13621458 0.72 CDK4 (0.53) CDK1CDK4CCND1CDK2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615634-B2 4-aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-10 US disclosed
US-7615634-B2 4-aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-10 US disclosed
US-7615634-B2 4-aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-10 US disclosed
US-7157455-B2 4-Aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2007-01-02 US disclosed
US-7157455-B2 4-Aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2007-01-02 US disclosed
US-20060229330-A1 4-aminopyrimidine-5-one derivatives BARTKOVITZ DAVID J 2006-10-12 US disclosed
EP-1628619-A2 4-AMINOPYRIMIDINE-5-ONE F.HOFFMANN-LA ROCHE AG (CH) 2006-03-01 EP disclosed
US-20040162303-A1 4-aminopyrimidine-5-one derivatives BARTKOVITZ DAVID JOSEPH (US) 2004-08-19 US disclosed
WO-2004069139-A2 4-AMINOPYRIMIDIN-5-YL-METHANONE DERIVATIVES FOR INHIBITION OF CDK4 ACTIVITY F.HOFFMANN-LA ROCHE AG (CH) 2004-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162303-A1 4-aminopyrimidine-5-one derivatives CDK4, CDKL4, CDK6 CDK1 6/4885CDK4 1/4885CCND1 32/4885
US-20060229330-A1 4-aminopyrimidine-5-one derivatives CDK4, CDKL4, CDK2 CDK1 6/4885CDK4 1/4885CCND1 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.